Orion Group Holdings, Inc.
NYSE:ORNEngineering & Construction
+$0.48 today
- Market cap
- $300.07M
- Beta
- 1.38
- P/E (TTM)
- 73.6
- EPS (TTM)
- $0.21
Volume 0.92M
Average 0.34M
ORN Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Orion Group Holdings, Inc.NYSE: ORN
Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026
Stock-based compensation grows in line with its trailing trend
Q1 FY2026 stock-based compensation of $1.39M rose 23.5% year over year, in line with the +23.5% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 14.0% from the prior quarter. Over 3 fiscal years it compounded at +25.5% a year.
Context
- Stock-based compensation amounted to 0.6% of revenue in FY2025, up 0.1 pp from a year earlier.
- Stock-based compensation increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +23.5% holds above the trailing-twelve-month pace of +23.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 5.45M USD
- Year-over-year change
- +35.9%
- 4-year CAGR
- +22.7%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.45M | +35.9% |
| FY2024 | 2024-12-31 | 4.01M | +96.3% |
| FY2023 | 2023-12-31 | 2.04M | -25.9% |
| FY2022 | 2022-12-31 | 2.75M | +14.7% |
| FY2021 | 2021-12-31 | 2.4M | — |
Stock-Based Compensation vs competitors
How ORN compares with its peers on the latest reported figures
- Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +23.5% is the 3rd highest of 10, against a peer median of -0.2%.
- Stock-based compensation amounts to 0.7% of revenue for ORN, versus a peer median of 0.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | £10.35M GBP | — | -25.3% | — | |
| LTM Apr 2026 | $8.35M USD | +9.7% | +17.8% | 1.6% | |
| LTM Mar 2026 | $7.63M USD | -12.7% | +4.2% | 0.9% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | $6.59M USD | +21.9% | +29.2% | 2.6% |
| LTM Mar 2026 | $5.9M USD | +23.5% | +25.5% | 0.7% | |
| LTM Apr 2026 | $2.78M USD | +37.4% | -25.9% | 0.7% | |
| LTM Feb 2026 | $2.74M USD | -18.0% | -17.3% | 2.3% | |
| LTM Feb 2026 | $1.93M USD | -51.5% | — | 0.5% | |
| LTM Mar 2026 | $1.48M USD | -11.7% | — | 8.0% | |
| LTM Apr 2026 | $1.03M USD | +121.1% | +27.2% | 0.1% | |
| LTM Mar 2026 | $401K USD | -0.2% | +2.8% | 0.5% | |
| Peer median (excluding ORN) | — | -0.2% | +3.5% | 0.9% | |
Competitors are the stored peer set for ORN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (14.56M) | (12.61M) | (17.88M) | (1.64M) | 2.49M |
| Depreciation & Amortization | 30.53M | 28.87M | 30.64M | 32.73M | 21.94M |
| Deferred Income Tax | (9K) | 13K | (103K) | (27K) | 52K |
| Stock-Based Compensation | 2.4M | 2.75M | 2.04M | 4.01M | 5.45M |
| Change in Working Capital | (8.1M) | (5.24M) | 2.41M | (21.7M) | (8.56M) |
| Accounts Receivables | 8.46M | (44.03M) | (23.71M) | (850K) | (32.76M) |
| Inventory | 371K | (1.49M) | (729K) | (554K) | 787K |
| Accounts Payables | 589K | 39.37M | (4.51M) | 16.02M | 11.09M |
| Other Working Capital | (17.52M) | 910K | 31.36M | (36.31M) | 12.33M |
| Other Non-Cash Items | (10.2M) | (4.22M) | 61K | (689K) | 6.7M |
| Operating Cash Flow | 69K | 9.57M | 17.18M | 12.68M | 28.07M |
| Capital Expenditures | (16.98M) | (14.58M) | (8.91M) | (14.09M) | (38.86M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 27.6M | 4.88M | 11.08M | 2.61M | 25.16M |
| Investing Cash Flow | 10.63M | (9.7M) | 2.17M | (11.48M) | (13.7M) |
| Debt Repayment | 845K | (7.27M) | 14.84M | (30.26M) | (42.32M) |
| Common Stock Issued | 0 | 0 | 0 | 26.42M | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (839K) | (1.1M) | (7.03M) | 25K | 2.93M |
| Financing Cash Flow | 6K | (8.37M) | 7.81M | (3.82M) | (39.39M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 10.7M | (8.51M) | 27.15M | (2.62M) | (25.03M) |
| Free Cash Flow | (16.91M) | (5.02M) | 8.27M | (1.42M) | (10.8M) |
Orion Group Holdings, Inc.
NYSE:ORN
Intrinsic Alpha fair value
Locked
Current Price
$7.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.